NCT00050206View on ClinicalTrials.gov

Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

May 31, 2005

Conditions

Bipolar Disorder

Interventions

DRUG

Olanzapine

DRUG

Placebo

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician., Indianapolis

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00050206 - Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder | Biotech Hunter | Biotech Hunter